2020
DOI: 10.1038/s42003-020-0903-7
|View full text |Cite
|
Sign up to set email alerts
|

An intact C-terminal end of albumin is required for its long half-life in humans

Abstract: Albumin has an average plasma half-life of three weeks and is thus an attractive carrier to improve the pharmacokinetics of fused therapeutics. The half-life is regulated by FcRn, a cellular receptor that protects against intracellular degradation. To tailor-design the therapeutic use of albumin, it is crucial to understand how structural alterations in albumin affect FcRn binding and transport properties. In the blood, the last C-terminal residue (L585) of albumin may be enzymatically cleaved. Here we demonst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 50 publications
(30 citation statements)
references
References 71 publications
0
30
0
Order By: Relevance
“…Last, we established the 24-hour concentration profiles of SHBG and albumin and observed a low-amplitude circadian rhythm in albumin levels with higher levels during the day compared to nighttime. Albumin has a half-life of circa 3 weeks and is not dependent on nutritional status, so this cannot explain the moderate circadian rhythm in albumin levels [ 67 , 68 ].…”
Section: Discussionmentioning
confidence: 99%
“…Last, we established the 24-hour concentration profiles of SHBG and albumin and observed a low-amplitude circadian rhythm in albumin levels with higher levels during the day compared to nighttime. Albumin has a half-life of circa 3 weeks and is not dependent on nutritional status, so this cannot explain the moderate circadian rhythm in albumin levels [ 67 , 68 ].…”
Section: Discussionmentioning
confidence: 99%
“…The absorbance was measured at 450 nm with a microplate reader (Molecular Devices). The plasma AXNA2 half-life was calculated using the following formula as described previously [ 17 ]: t 1/2 = log 0.5/(log Ae/A0) × t , where t 1/2 is the half-life, Ae is the amount of AXNA2 remaining, A0 is the amount of AXNA2 on 2 h, and t is the elapsed time.…”
Section: Methodsmentioning
confidence: 99%
“…The absorbance was measured at 450 nm with a microplate reader (Molecular Devices). The plasma ANXA2 half-life was calculated using the following the formula as described previously ( Nilsen et al, 2020 ): t 1/2 = log 0.5/(log Ae/A0)× t, where t 1/2 is the half-life, Ae is the amount of ANXA2 remaining, A0 is the amount of ANXA2 on 2 h, and t is the elapsed time.…”
Section: Methodsmentioning
confidence: 99%